Premium
Beta‐amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study
Author(s) -
Clark Lindsay R.,
Racine Annie M.,
Koscik Rebecca L.,
Okonkwo Ozioma C.,
Engelman Corinne D.,
Carlsson Cynthia M.,
Asthana Sanjay,
Bendlin Barbara B.,
Chappell Rick,
Nicholas Christopher R.,
Rowley Howard A.,
Oh Jennifer M.,
Hermann Bruce P.,
Sager Mark A.,
Christian Bradley T.,
Johnson Sterling C.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.12.009
Subject(s) - cognitive decline , cognition , apolipoprotein e , cohort , pittsburgh compound b , alzheimer's disease , psychology , medicine , cognitive skill , gerontology , audiology , demography , cognitive impairment , disease , dementia , psychiatry , sociology
The present study investigated the relationship between beta‐amyloid (Aβ) and cognition in a late middle‐aged cohort at risk for Alzheimer's disease (AD). Methods One eighty‐four participants (mean age = 60; 72% parental history of AD) completed a [C‐11]Pittsburgh compound B positron emission tomography scan and serial cognitive evaluations. A global measure of Aβ burden was calculated, and composite scores assessing learning, delayed memory, and executive functioning were computed. Results Higher Aβ was associated with classification of psychometric mild cognitive impairment (MCI) at follow‐up ( P < .01). Linear mixed effects regression results indicated higher Aβ was associated with greater rates of decline in delayed memory ( P < .01) and executive functioning ( P < .05). Apolipoprotein E ( APOE ) ε4 status moderated the relationship between Aβ and cognitive trajectories ( P values <.01). Discussion In individuals at risk for AD, greater Aβ in late middle age is associated with increased likelihood of MCI at follow‐up and steeper rates of cognitive decline.